Tezspire nearly eliminated the need for surgery, reducing surgical intervention by 98 per cent
The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
Conducted entirely in Europe across forty sites in five countries, this rigorous study met all clinical endpoints
Wegovy achieved significant weight loss with one in three study participants losing 20% or more body weight
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Encouraging early detection and breaking the silence around men’s health
IND application for EB-003 expected in early 2026
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Subscribe To Our Newsletter & Stay Updated
